Table 3 Patient details of panel positive in ESCC patients
From: Inducing multiple antibodies to treat squamous cell esophageal carcinoma
Panel | |||
|---|---|---|---|
Positive | - | + | |
Number | 58 (67.1%) | 27 (32.9) | |
Gender | |||
Male (%) | 49 (57.6) | 25 (29.4) | p=0.490 |
Female | 9 (10.6) | 2 (2.4) | |
Mean age ± s.d. (years) | 68.4 ± 7.5 | 70.5 ± 8.4 | |
Age range (years) | 45-84 | 56-85 | |
Depth of tumor invasion | |||
T1 | 18 (21.2) | 10 (11.8) | p=0.514 |
T2 | 6 (7.1) | 2 (2.4) | |
T3 | 23 (27.0) | 6 (7.1) | |
T4 | 11 (12.9) | 9 (10.6) | |
Lymph node metastasis | |||
Positive | 38 (44.7) | 18 (21.2) | p=0.887 |
Negative | 20 (23.5) | 9 (10.6) | |
Distant metastasis | |||
Positive | 14 (16.5) | 5 (5.9) | p=0.765 |
Negative | 44 (51.8) | 22 (25.9) | |
TNM stage | |||
I | 17 (20.0) | 7 (8.2) | p=0.999 |
II | 7 (8.2) | 4 (4.7) | |
III | 16 (18.8) | 7 (8.2) | |
IV | 18 (21.2) | 9 (10.6) | |